Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 488

1.

Programmes and principles in treatment of multidrug-resistant tuberculosis.

Mukherjee JS, Rich ML, Socci AR, Joseph JK, Virú FA, Shin SS, Furin JJ, Becerra MC, Barry DJ, Kim JY, Bayona J, Farmer P, Smith Fawzi MC, Seung KJ.

Lancet. 2004 Feb 7;363(9407):474-81. Review.

PMID:
14962530
[PubMed - indexed for MEDLINE]
2.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
[PubMed - indexed for MEDLINE]
3.

Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment.

Ormerod LP.

Br Med Bull. 2005 Jun 14;73-74:17-24. Print 2005. Review.

PMID:
15956357
[PubMed - indexed for MEDLINE]
4.

Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Health.

Telzak EE, Chirgwin KD, Nelson ET, Matts JP, Sepkowitz KA, Benson CA, Perlman DC, El-Sadr WM.

Int J Tuberc Lung Dis. 1999 Apr;3(4):337-43.

PMID:
10206505
[PubMed - indexed for MEDLINE]
5.

Multidrug-resistant tuberculosis of the spine--is it the beginning of the end? A study of twenty-five culture proven multidrug-resistant tuberculosis spine patients.

Pawar UM, Kundnani V, Agashe V, Nene A, Nene A.

Spine (Phila Pa 1976). 2009 Oct 15;34(22):E806-10. doi: 10.1097/BRS.0b013e3181af7797.

PMID:
19829244
[PubMed - indexed for MEDLINE]
6.

Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.

Pablos-Mendez A, Gowda DK, Frieden TR.

Bull World Health Organ. 2002;80(6):489-95; discussion 495-500.

PMID:
12132008
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.

Migliori GB, Sotgiu G, Jaramillo E, Mirzayev F, Centis R, Colvin C, Richardson MD.

Int J Tuberc Lung Dis. 2009 Oct;13(10):1305-8.

PMID:
19793438
[PubMed - indexed for MEDLINE]
8.

Cost-effectiveness of treating multidrug-resistant tuberculosis.

Resch SC, Salomon JA, Murray M, Weinstein MC.

PLoS Med. 2006 Jul;3(7):e241.

PMID:
16796403
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Multi-drug resistant tuberculosis burden and risk factors: an update.

Marahatta SB.

Kathmandu Univ Med J (KUMJ). 2010 Jan-Mar;8(29):116-25. Review.

PMID:
21209520
[PubMed - indexed for MEDLINE]
10.

[Multidrug resistant tuberculosis in Romania in the last years (2004-2007)--an extremely important social phenomenon].

Marica C, Didilescu C, Chiotan D, Galie N, Tănăsescu M, Popescu-Hagen M, Popa M.

Pneumologia. 2008 Oct-Dec;57(4):195-200. Romanian.

PMID:
19186681
[PubMed - indexed for MEDLINE]
11.

Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.

Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2009 Feb 13;58(RR-3):1-43.

PMID:
19214162
[PubMed - indexed for MEDLINE]
Free Article
12.

Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis.

Ahmad S, Mokaddas E.

Respir Med. 2009 Dec;103(12):1777-90. doi: 10.1016/j.rmed.2009.07.010. Epub 2009 Aug 5. Review.

PMID:
19660927
[PubMed - indexed for MEDLINE]
Free Article
13.

[Multiple drug resistance: a threat for tuberculosis control].

Cardoso EM.

Rev Panam Salud Publica. 2004 Jul;16(1):68-73. Portuguese.

PMID:
15333267
[PubMed - indexed for MEDLINE]
14.
15.

[Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].

Kang WL, Xie YG, Tan WG, Chu NH, Li L, You YH, Yang YZ, Wang XM, Yan XL, Miao ZP, Duanmu HJ.

Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Feb;30(2):179-83. Chinese.

PMID:
19565883
[PubMed - indexed for MEDLINE]
16.

[Drug resistant tuberculosis].

Zwolska Z, Augustynowicz-Kopeć E.

Pol Merkur Lekarski. 2011 May;30(179):362-6. Review. Polish.

PMID:
21675144
[PubMed - indexed for MEDLINE]
17.

HIV infection and multidrug-resistant tuberculosis: the perfect storm.

Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A, Castro KG, Weyer K.

J Infect Dis. 2007 Aug 15;196 Suppl 1:S86-107. Review.

PMID:
17624830
[PubMed - indexed for MEDLINE]
Free Article
18.

High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia.

Jugheli L, Rigouts L, Shamputa IC, Bram de Rijk W, Portaels F.

Int J Tuberc Lung Dis. 2008 May;12(5):561-6.

PMID:
18419893
[PubMed - indexed for MEDLINE]
19.

Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in Iran.

Tabarsi P, Nooraki A, Mirsaeidi M, Amiri M, Baghaei P, Farnia P, Kazempour M, Heidarnazhad H, Alipanah N, Mansouri D, Masjedi MR.

Respirology. 2008 Jan;13(1):108-11. doi: 10.1111/j.1440-1843.2007.01201.x.

PMID:
18197919
[PubMed - indexed for MEDLINE]
20.

Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YS, Kim K, Kim J, Shim YM, Koh WJ.

Clin Infect Dis. 2008 Aug 15;47(4):496-502. doi: 10.1086/590005.

PMID:
18611154
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk